Wolverine Trading
GCVRZ

Wolverine Trading’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Wolverine Trading’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,791
Closed -$4K – 5649
2016
Q4 		$4K Hold
11,791
– – ﹤0.01% 4351
2016
Q3 		$3K Hold
11,791
– – ﹤0.01% 4551
2016
Q2 		$3K Buy
+11,791
New +$2.03K ﹤0.01% 3945

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Wolverine Trading's GCVRZ Position: Q1 2017 in Review

Wolverine Trading sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2017, closing a stake of 11,791 shares — an estimated $4K sold.

Wolverine Trading first reported a position in GCVRZ in Q2 2016 and held it in 3 quarters. The position peaked at $4K in Q4 2016. 111 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2017.

  • Wolverine Trading reported no remaining Sanofi Contingent Value Rights position as of Q1 2017 after selling out during the quarter.
  • Wolverine Trading sold 11,791 Sanofi Contingent Value Rights shares in Q1 2017, an estimated $4K.
  • Wolverine Trading first reported a position in Sanofi Contingent Value Rights in Q2 2016 and held it in 3 quarters.
  • Wolverine Trading's Sanofi Contingent Value Rights position peaked at $4K in Q4 2016.
  • 111 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2017.

Based on Wolverine Trading's 13F filing for Q1 2017, filed 15 May 2017.